List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 141 studies with search of:   "Lapatinib"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Ductal Carcinoma In Situ (DCIS) Lapatinib Trial
Condition: Breast Cancer
Interventions: Drug: GW572016;   Drug: GW572016;   Drug: GW 572016;   Drug: Placebo
2 Active, not recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (GW572016)
3 Recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (Tykerb)
4 Completed Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
Condition: Adenocarcinoma
Intervention: Drug: Lapatinib (GW572016) oral tablets
5 Recruiting Neoadjuvant GW572016 to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Drug: GW572016;   Drug: lapatinib
6 Completed Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: GW572016 (Lapatinib)
7 Not yet recruiting A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: oral topotecan (SK&F-104864); lapatinib (GW572016)
8 Active, not recruiting Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: lapatinib (GW572016)
9 Active, not recruiting A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Intervention: Drug: GW572016 (lapatinib)
10 Active, not recruiting Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
Condition: Metastatic Cervical Cancer
Intervention: Drug: pazopanib (GW786034), lapatinib (GW572016)
11 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
12 Active, not recruiting Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: lapatinib (GW572016)
13 Recruiting Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
Conditions: Metastatic Breast Cancer;   First or Second Line Therapy
Intervention: Drug: Lapatinib/nab-Paclitaxel
14 Recruiting Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Condition: Metastatic Breast Cancer
Interventions: Drug: lapatinib (GW572016) oral tablets;   Drug: paclitaxel infusion
15 Not yet recruiting A Phase II Study to Evaluate the Efficacy of Lapatinib in the Blood of Women With Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: Lapatinib
16 Recruiting Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Condition: Early Breast Cancer
Intervention: Drug: Lapatinib
17 Recruiting Phase I Study of Ixabepilone + Lapatinib +/- Capecitabine to Treat HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Locally Advanced Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Ixabepilone + lapatinib;   Drug: Ixabepilone + lapatinib + capecitabine
18 Recruiting Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
Condition: Hormone-Sensitive Breast Cancer
Intervention: Drug: lapatinib
19 Recruiting Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer;   Advanced Breast Cancer;   HER2/Neu-Positive Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Lapatinib
20 Recruiting Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
Conditions: Gastric Cancer;   Gastro Esophageal(GE)Junction Cancer
Intervention: Drug: Lapatinib and Capecitabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services